Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Clinical trial NCT04163900 · TERMINATED

Trial details

NCT number: NCT04163900
Sponsor: NuCana plc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2019-12-24
Primary completion: 2022-03-02
Enrollment: 773

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.